AzTrials
AzTrials

Limb-girdle Muscular DystrophyNCT06399770

The Role of Muscle Ultrasound in Assessment of Sample of Patients With Limb-girdle Muscular Dystrophy

An observational study of Limb-girdle Muscular Dystrophy, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. to detect the characteristic patterns of muscle involvement in suspected cases of LGMD using muscle ultrasound 2. to use the muscle ultrasound findings clinically categorized the different types of LGMD 3. to correlate the muscle ultrasound findings with the findings of the other assissed scales Read more about this study

Who is it for?
Any age
Conditions the study is for
Limb-girdle Muscular Dystrophy
What is being tested?
Muscle ultrasound
Type of treatment
Medical device
How many people
50 participants
Where
No sites listed yet
Study dates
1 Jun 2024to 1 Jul 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: * Patients presented with clinical manifestations suggestive of LGMD who presented with gradual progressive limb-girdle weakness ,myopathic changes on electromyography and elevated creatine phosphokinase serum level * age and sex matched healthy control group as a normal referencce

Who may be able to join

  • gender : both sex are included Willingness to participate in the study and to be subjected to disease related examination and assessments Willing and able to provide informd consent

Who cannot join

  • patients unable to give informed consent Patients with acute or subacute onset of symptoms of muscle involvement including inflammatory myopathies Patients with systemic diseases causing secondary myopathy

Trial locations and contacts

No sites are listed yet.

Abanoub Bassem Fikry contact

+201210927033

Abanoubbassem2@icloud.Com

Ghaydaa Ahmed Shehata contact

+201004489683

Ghaydaa@yahoo.com

About this study

  1. to detect the characteristic patterns of muscle involvement in suspected cases of LGMD using muscle ultrasound
  2. to use the muscle ultrasound findings clinically categorized the different types of LGMD
  3. to correlate the muscle ultrasound findings with the findings of the other assissed scales
Read the detailed description

Limb-girdle muscular dystrophies (LGMD) are muscular dystrophies that affect skeletal muscles, mostly proximal (hips and shoulder muscles). They are caused by a mutation in a gene encoding a protein, which is specific to each subtype. LGMD inheritance is either autosomal dominant or recessive. Several types of LGMD were described depending on the causative mutations (1). LGMD is one of inherited myopathies that characterized by selective involvement of muscles. Selectivity is a sign of muscle diseases and helps direct the diagnosis; however, it cannot always be identified clinically; consequently, the importance of using muscle MRI and ultrasound are to detect this selectivity and aid in the diagnosis (2). Ultrasound with a high resolution enables viewing of the muscle, nerve, and nearby structures and can provide real-time information in neuromuscular illnesses (3). Muscle Ultrasound (MUS) can detect the same patterns of muscle affection as MRI (4). In addition, it is safe, accessible, low-cost, and free of ionizing radiation, with no known contraindications and no difficulties associated with MRI, such as claustrophobia, metallic implants, and the requirement for sedation in children; hence, it can be used as a supplemental technique to electro- diagnosis (5). Ultrasound can provide real-time information related to muscle activation and movement patterns; so, selective substitution of muscle ultrasound for MRI can result in significant cost-saving for the health care system (6). However, its primary drawback is that it is operator-dependent and has a limited ability to image deeper structures (7). According to studies, MUS can provide a key provisional probable diagnosis, especially when genetic diagnosis is not accessible or expensive, or to provide guide to the proper genetic testing when it is available (2, 8). In limb girdle pattern of weakness patients, MUS assisted diagnose quadriceps sparing myopathy, selective affection of one head of gastrocnemius as medial head and soleus more than lateral head in FKRP (LGMD2I) and calpain-3 deficiency (LGMD2A), and selective affection of lateral head as in LGMD2B.

(dysferlin) (9). MUS can also help diagnose the treatable types of limb girdle myopathies like POPME by recognizing specific muscle involvement patterns (2). Few research (10), utilized the MUS to detect suspected LGMD, and none compared the MUS findings with those of the different psychometric measures. The present study aims to we aimed to evaluate the role of MUS in the assessment of patients with suspected LGMD to identify characteristic patterns these of muscle involvement in suspected cases of LGMD and to correlate changes with findings of the different psychometric scales.

Being tested
Muscle ultrasound
Medical subject headings
Muscular Dystrophies, Limb-Girdle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle ultrasoundDevice

    Role of muscle ultrasound in LGMD

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The role of muscle ultrasound in assessment of a sample of patients with limb-girdle muscular dystrophy

    The role of muscle ultrasound in assessment of sample of patients with LGMD

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2024
  2. Study start1 Jun 2024 (estimated)
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion1 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06399770
Sponsor's protocol ID
Limb-girdle muscular dystrophy
Status last verified
May 2024
First submitted
1 May 2024
Last updated
6 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Limb-girdle Muscular Dystrophy, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 May 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Abanoub Bassem Fikry (+201210927033, Abanoubbassem2@icloud.Com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The role of muscle ultrasound in assessment of a sample of patients with limb-girdle muscular dystrophy (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in